← Scroll for more →
Mesoblast Ltd (MESO)
Biological Products, (No Diagnostic Substances)
Latest Price
$14.65
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.44
P/B Ratio
32.94
Institutional Ownership
0.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Jane Street Group, LLC | 1.22M | $16.0M | 0.09% | +371.7K | 2026-06-30 |
| Citadel Advisors LLC | 817.6K | $11.0M | 0.06% | +272.2K | 2026-06-30 |
| Morgan Stanley | 718.6K | $9.0M | 0.06% | +204.2K | 2026-06-30 |
| BlackRock, Inc. | 664.3K | $8.0M | 0.05% | +33.4K | 2026-06-30 |
| Goldman Sachs Group Inc | 395.6K | $5.0M | 0.03% | -1.6K | 2026-06-30 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 259.7K | $3.0M | 0.02% | -- | 2026-06-30 |
| UBS Group AG | 200.1K | $2.0M | 0.02% | +67.5K | 2026-06-30 |
| Arax Advisory Partners | 168.0K | $2.0M | 0.01% | +143.6K | 2026-06-30 |
| Bank of America Corp | 100.0K | $1.0M | 0.01% | -4 | 2026-06-30 |
| Penbrook Management LLC | 87.1K | $1.0M | 0.01% | -- | 2026-06-30 |